A novel monoclonal antibody for detection of folate receptor alpha in paraffin-embedded tissues

Hybridoma

Volumn 26, Issue 5, 2007, Pages 281-288

  Smith, Amy E ^a,b   Pinkney, Michael ^a   Piggott, Nigel H ^a   Calvert, Hilary ^b   Milton, Ian D ^a   Lunec, John ^b  

^a Novocastra Laboratories Ltd   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLATE RECEPTOR; FOLATE RECEPTOR ALPHA; FOLIC ACID ANTAGONIST; HYBRID PROTEIN; MONOCLONAL ANTIBODY; PARAFFIN; PEMETREXED; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BENIGN TUMOR; CELL MEMBRANE; CYTOPLASM; DRUG RECEPTOR BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; FEMALE; HYBRIDOMA; IMMUNOHISTOCHEMISTRY; KIDNEY PROXIMAL TUBULE; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; OVARY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TISSUE SECTION; TROPHOBLAST; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; CARRIER PROTEINS; CELL LINE; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; PARAFFIN EMBEDDING; RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED;

EID: 35848939610     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2007.0512     Document Type: Article

References (29)

1. Lucock M: Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 2000;71:121-138.
2. Choi SW, and Mason JB: Folate and carcinogenesis: an integrated scheme. J Nutri 2000;130:129-132.
3. Henderson GB: Folate-binding proteins. Annu Rev Nutri 1990;10:319-335.
4. Antony AC: Folate receptors. Annu Rev Nutri 1996;16:501-521.
5. Elnakat H, and Ratnam M: Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy. Adv Drug Delivery Rev 2004;56:1067-1084.
6. Spiegelstein O, Eudy JD, and Finnell RH: Identification of two novel folate receptor genes in humans and mouse. Gene 2000;258:117-125.
7. Saiwaka Y, Price D, Hance KW, Chen TY, and Elwood PC: Structural and functional analysis of the human KB cell folate receptor gene p4 promoter: co-operation of three clustered Sp-1 binding sites with initiator region for basal promoter activity. Biochemistry 1995;34:9951-9961.
8. Antony AC: The biological chemistry of folate receptors. Blood 1992;79:2807-2820.
9. Campbell IG, Jones TA, Foulkes WD, and Trowsdale J: Folate binding protein is a marker for ovarian cancer. Cancer Res 1991;51:5329-5338.
10. Brown D, and Waneck GL: Glycosyl-phosphatidylinositol-anchored membrane proteins. J Am Soc Nephrol 1992;3:895-906.
11. Tran T, Shatnawi A, Zheng X, Kelley KM, and Ratnam M: Enhancement of folate receptor alpha expression in tumour cells through the glucocorticoid receptor: a promising means to improved tumour detection and targeting. Cancer Res 2005;65:4431-4441.
12. Elwood PC, Nachmanoff K, Saikawa Y, Page ST, Pacheco P, Roberts S, and Chung KN: The divergent 5 termini of the human folate receptor (hFR) mRNA's originate from two tissue specific promoters and alterative splicing: characterisation of the hFR gene structure. Biochemistry 1997;36:1467-1478.
13. Ratnam M, Marquardt H, Duhring JL, and Freisheim JH: Homologous membrane folate binding proteins in human placenta, cloning and sequence of a cDNA. Biochemistry 1989;28:8249-8254.
14. Ross JF, Wang H, Behm FG, Mathew P, Wu M, Booth R, and Ratnam M: Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukaemia. Cancer 1999;85:348-357.
15. Antony AC, Kane MA, Portillo RM, Elwood PC, and Kolhouse J: Studies of the role of a particulate folate binding proteinin the uptake of 5-methyltetrahydrofolate by cultured human KB cells. J Biol Chem 1985;260:14911-14917.
16. Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, and Leamon C: Folate receptor expression in carcinomas and normal tissues determined by quantitative radioligand binding assay. Ann Biochem 2005;338:284-293.
17. Toffoli G, Cernigoi C, Russo A, Gallo A, Bagnoli M, and Boiocchi M: Overexpression of folate binding protein in ovarian cancers. Int J Cancer 1997;74:193-198.
18. Toffoli G, Russo A, Gallo A, Cernigoi C, Miotti S, Sorio R, Tumolo S, and Boicchi M: Expression of folate binding protein as a prognostic factor for response to platinum containing chemotherapy and survival in human ovarian cancer. Int J Cancer 1998;79:121-126.
19. Weitman SD, Weinberg LR, Coney LR, Zurawski DS, Jennings DS, and Kamen BA: Cellular localisation of the folate receptor-potential role in drug toxicity and folate homeostasis. Cancer Res 1992;52:6708-6711.
20. Lu Y, and Low PS: Immunotherapy of folate receptor-expressing tumours: review of recent advances and future prospects. J Controlled Rel 2003;91:17-29.
21. Mangiarotti F, Miotti S, Galmozzi E, Mazzi M, Sforzini S, Canevari S, and Tomassetti A: Functional effect of point mutations in the alpha folate receptor gene of CABA I ovarian carcinoma cells. J Cell Biochem 2001;81:488-498.
22. Ross JF, Chaudhuri PK, and Ratnam M: Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 1994;73:2431-2443.
23. Veggian R, Fasolato S, Menard D, Minucci D, Pizzetti P, Regazzoni M, Tagliabue E, and Colnaghi MI: Immunohistochemical reactivity of a monoclonal antibody prepared against human ovarian carcinoma on normal and pathological female genital tissues. Tumori 1989;75:510-513.
24. Wu M, Gunning W, and Ratnam M: Expression of folate receptor type alpha in relation to cell type, malignancy and differentiation in ovary, uterus, and cervix. Cancer Epidemiol Biomarkers Prev 1999;8:775-782.
25. Evans CO, Young AN, Brown MR, Brat DJ, Parks JS, Neish AS, and Oyesiku NM: Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription polymerase chain reaction. J Clin Endocrinol Metab 2001;86:3097-3107.
26. Bueno R, Appasani K, Mercer H, Lester S, and Sugarbaker D: The alpha folate receptor is highly activated in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001;121:223-233.
27. Chattopadhyay S, Zhao R, Krupenko SA, Krupenko N, and Goldman ID: The inverse relationship between reduced folate carrier function and pemetrexed activity in a human colon cancer cell line. Mol Cancer Ther 2006;5:438-449.
28. Khokhar NZ, Lam AF, Rusch VW, and Sirotnak FM: Despite some folate receptor alpha in human mesothelioma cells, internalization of methotrexate is predominantly carrier mediated. J Thorac Cardiovasc Surg 2002;123:862-868.
29. Jackman AL, Theti DS, and Gibbs DD: Antifolates targeted specifically to the folate receptor. Adv Drug Delivery Rev 2004;56:1111-1125.